The revenue change in the 'Anti-Diabetes Drugs' segment of the pharmaceuticals market in Italy was forecast to continuously decrease between 2024 and 2029 by in total 3.3 percentage points. According to this forecast, in 2029, the indicator will have decreased for the sixth consecutive year to 5.59 percent.
Data provided by Statista Market Insights are estimates.
Definition: The Anti-Diabetes Drugs market covers drugs to treat the metabolism disorder diabetes mellitus. It includes insulin and non-insulinotropic drugs such as glucagen-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors. While patients with type 1 diabetes require lifelong insulin therapy, type 2 diabetes can also be treated with medication.
Additional information: Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).
Company examples: Novo Nordisk, Eli Lilly, Sanofi, Merck & Co
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (June 26, 2024). Revenue growth of anti-diabetes drugs in Italy between 2019 and 2029 [Graph]. In Statista. Retrieved September 20, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1342833/anti-diabetes-drugs-market-revenue-growth-italy
Statista. "Revenue growth of anti-diabetes drugs in Italy between 2019 and 2029." Chart. June 26, 2024. Statista. Accessed September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1342833/anti-diabetes-drugs-market-revenue-growth-italy
Statista. (2024). Revenue growth of anti-diabetes drugs in Italy between 2019 and 2029. Statista. Statista Inc.. Accessed: September 20, 2024. https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1342833/anti-diabetes-drugs-market-revenue-growth-italy
Statista. "Revenue Growth of Anti-diabetes Drugs in Italy between 2019 and 2029." Statista, Statista Inc., 26 Jun 2024, https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1342833/anti-diabetes-drugs-market-revenue-growth-italy
Statista, Revenue growth of anti-diabetes drugs in Italy between 2019 and 2029 Statista, https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1342833/anti-diabetes-drugs-market-revenue-growth-italy (last visited September 20, 2024)
Revenue growth of anti-diabetes drugs in Italy between 2019 and 2029 [Graph], Statista, June 26, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/forecasts/1342833/anti-diabetes-drugs-market-revenue-growth-italy